ArticleThe Journal of infectious diseases2009

Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria.

Lena Serghides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.